DK1267847T3 - 5HT2-antagonist til regulering af IOP og behandling af glaucom - Google Patents

5HT2-antagonist til regulering af IOP og behandling af glaucom

Info

Publication number
DK1267847T3
DK1267847T3 DK00978627T DK00978627T DK1267847T3 DK 1267847 T3 DK1267847 T3 DK 1267847T3 DK 00978627 T DK00978627 T DK 00978627T DK 00978627 T DK00978627 T DK 00978627T DK 1267847 T3 DK1267847 T3 DK 1267847T3
Authority
DK
Denmark
Prior art keywords
iop
glaucoma
antagonist
regulation
treatment
Prior art date
Application number
DK00978627T
Other languages
Danish (da)
English (en)
Inventor
Jesse A May
Anura P Dantanarayana
Original Assignee
Alcon Inc
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Yamanouchi Pharma Co Ltd filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1267847T3 publication Critical patent/DK1267847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00978627T 2000-03-17 2000-11-14 5HT2-antagonist til regulering af IOP og behandling af glaucom DK1267847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028800P 2000-03-17 2000-03-17
PCT/US2000/031246 WO2001070207A2 (fr) 2000-03-17 2000-11-14 Agonistes de 5ht2 permettant de commander la pression intra-oculaire elevee et de traiter le glaucome

Publications (1)

Publication Number Publication Date
DK1267847T3 true DK1267847T3 (da) 2004-03-08

Family

ID=22700724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00978627T DK1267847T3 (da) 2000-03-17 2000-11-14 5HT2-antagonist til regulering af IOP og behandling af glaucom

Country Status (19)

Country Link
EP (1) EP1267847B1 (fr)
JP (1) JP2003527415A (fr)
KR (1) KR100499903B1 (fr)
CN (1) CN1231214C (fr)
AR (1) AR026707A1 (fr)
AT (1) ATE258793T1 (fr)
AU (2) AU1607101A (fr)
BR (1) BR0017158A (fr)
CA (1) CA2401969A1 (fr)
DE (1) DE60008151T2 (fr)
DK (1) DK1267847T3 (fr)
ES (1) ES2210018T3 (fr)
MX (1) MXPA02008548A (fr)
PL (1) PL358296A1 (fr)
PT (1) PT1267847E (fr)
TR (1) TR200400424T4 (fr)
TW (1) TW546139B (fr)
WO (1) WO2001070207A2 (fr)
ZA (1) ZA200206852B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
EP1581209A4 (fr) 2002-12-13 2009-03-11 Alcon Inc Nouveaux analogues de benzopyranne et leur utilisation pour le traitement du glaucome
WO2005053688A1 (fr) * 2003-11-26 2005-06-16 Alcon, Inc. Furo[2,3-g] indazoles substitues destines au traitement du glaucome
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
EP1792629A4 (fr) 2004-08-25 2010-08-25 Takeda Pharmaceutical Agents preventifs/remedes pour l'incontinence de stress et procede de selecetion de ceux-ci
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
EP2727585A1 (fr) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited Méthode de dépistage in-vivo
EP2216023A4 (fr) 2007-11-15 2013-03-13 Takeda Pharmaceutical Dérivé de pyridine condensé et son utilisation
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030548A1 (fr) * 1997-01-13 1998-07-16 Yamanouchi Pharmaceutical Co., Ltd. AGONISTES DU RECEPTEUR 5-HT2c ET DERIVES D'AMINOALKYLINDAZOLE
WO2001040183A1 (fr) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1 h-indoles pour traiter le glaucome

Also Published As

Publication number Publication date
CA2401969A1 (fr) 2001-09-27
KR20030095185A (ko) 2003-12-18
WO2001070207A3 (fr) 2002-05-10
PL358296A1 (en) 2004-08-09
HK1050143A1 (en) 2003-06-13
ATE258793T1 (de) 2004-02-15
EP1267847A2 (fr) 2003-01-02
TR200400424T4 (tr) 2004-03-22
DE60008151D1 (de) 2004-03-11
ZA200206852B (en) 2003-08-27
CN1231214C (zh) 2005-12-14
AU2001216071B2 (en) 2004-12-02
ES2210018T3 (es) 2004-07-01
JP2003527415A (ja) 2003-09-16
BR0017158A (pt) 2003-06-03
WO2001070207A2 (fr) 2001-09-27
EP1267847B1 (fr) 2004-02-04
TW546139B (en) 2003-08-11
CN1450897A (zh) 2003-10-22
PT1267847E (pt) 2004-05-31
KR100499903B1 (ko) 2005-07-07
DE60008151T2 (de) 2004-07-08
AR026707A1 (es) 2003-02-26
MXPA02008548A (es) 2004-08-23
AU1607101A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
NO20035609D0 (no) Fremgangsmåte for kontinuerlig naftabehandling
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1379224T3 (da) Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese
DE60215179D1 (de) Dolastatin 10 derivate
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
PL358296A1 (en) 5ht2 agonists for controlling iop and treating glaucoma
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
EP1558238A4 (fr) Beta-hydroxyphenylaldylamines et utilisation de celles-ci pour traiter le glaucome
EP1455780A4 (fr) Nouveaux derives de benzodifurane imidazoline et de benzofurane imidazoline et leur utilisation pour traiter le glaucome
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
NO20025760L (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
DK1493442T3 (da) Reboxetin til behandling af perifer neuropati
NO20031779D0 (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom